Am Heart J

1. KIM MC, Ahn JH, Hyun DY, Lim Y, et al
   Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial.
   Am Heart J. 2024 Apr 17:S0002-8703(24)00078-4. doi: 10.1016/j.ahj.2024.
   

   >> Share

   
   

   
   Am J Cardiol

2. EDMONSTON D, Mulder H, Lydon E, Chiswell K, et al
   Kidney and Cardiovascular Effectiveness of Empagliflozin Compared to Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes.
   Am J Cardiol. 2024 Apr 17:S0002-9149(24)00268.
   

   >> Share

   
   
3. OCHIUMI Y, Tsuchikane E, Kishi K, Okada H, et al
   The Characteristics of Primary Retrograde Approach Selection for Native Coronary Chronic Occlusion With Short Occlusion Length from the Japanese CTO-PCI Expert Registry.
   Am J Cardiol. 2024;218:113-120.
   

   >> Share

   
   
4. YOU Y, Zeng N, Wu W, Liu B, et al
   Association of Serum Homocysteine with Peripheral Arterial Disease in Non-Diabetic Patients: A Study Based on National Health and Nutrition Examination Survey Database.
   Am J Cardiol. 2024 Mar 6:S0002-9149(24)00169.
   

   >> Share

   
   
5. FILHO RCF, Generoso G, Cardoso R, Jones SR, et al
   GlycA Levels Independently Predict Coronary Artery Calcium Incidence and Progression in the ELSA-Brasil Cohort (Brazilian Longitudinal Study of Adult Health).
   Am J Cardiol. 2024 Apr 16:S0002-9149(24)00265.
   

   >> Share

   
   
6. DOKOLLARI A, Rosati F, Muneretto C, Amabile A, et al
   Development of a Risk Score for Long-term Survival and MACCE After Coronary Artery Bypass Grafting Surgery.
   Am J Cardiol. 2024 Apr 10:S0002-9149(24)00241.
   

   >> Share

   
   

   
   Am J Emerg Med

7. NAKAJIMA S, Matsuyama T, Kandori K, Okada A, et al
   Impact of time to revascularization on outcomes in patients after out-of-hospital cardiac arrest with STEMI.
   Am J Emerg Med. 2024;79:136-143.
   

   >> Share

   
   
8. TEKIN G, Tekin YK
   Occlusive coronary artery disease: A diagnosis that must be excluded.
   Am J Emerg Med. 2024 Apr 9:S0735-6757(24)00162.
   

   >> Share

   
   

   
   Angiology

9. OZBAY MB, Nriagu BN, Ozbay HS
   Letter: Serum Uric Acid to Albumin Ratio in Chronic Coronary Artery Disease Patients.
   Angiology. 2024 Apr 17:33197241248728. doi: 10.1177/00033197241248728.
   

   >> Share

   
   
10. ENGIN M, Ari H
    Contrast-Induced Acute Kidney Injury after Elective Percutaneous Coronary Interventions.
    Angiology. 2024 Apr 17:33197241248777. doi: 10.1177/00033197241248777.
    

    >> Share

    
    

    
    Ann Intern Med

11. KIRSCHNER J, Hunter B
    In suspected ACS, hs-cTnI- vs. c-cTnI-guided care was associated with improved outcomes at 5 y in certain subgroups.
    Ann Intern Med. 2024;177:JC41.
    

    >> Share

    
    

    
    Ann Thorac Surg

12. FERNANDEZ-CISNEROS A, Feins E, Newburger J, Sekhavat S, et al
    RE-REPAIR AFTER TRANSLOCATION OF AN ANOMALOUS LEFT CORONARY ARTERY.
    Ann Thorac Surg. 2024 Apr 13:S0003-4975(24)00282.
    

    >> Share

    
    

    
    BMJ

13. MOK PLH, Carr MJ, Guthrie B, Morales DR, et al
    Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study.
    BMJ. 2024;385:e076268.
    

    >> Share

    
    
14. VINTER N, Cordsen P, Johnsen SP, Staerk L, et al
    Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study.
    BMJ. 2024;385:e077209.
    

    >> Share

    
    

    
    Can J Cardiol

15. GUERRA PG, Simpson CS, Van Spall HGC, Asgar AW, et al
    Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive.
    Can J Cardiol. 2024;40:500-523.
    

    >> Share

    
    
16. AMJAD M
    High-Sensitivity Cardiac Troponin I Thresholds to Identify Myocardial Injury After Noncardiac Surgery.
    Can J Cardiol. 2024;40:734.
    

    >> Share

    
    
17. DESSUREAULT A, Massie E, Fish D, Parent MC, et al
    Cardiomyopathy and Cardiogenic Shock Caused by Juvenile Hemochromatosis Improving With Guideline-Directed Medical Therapy Despite High Ferritin Levels.
    Can J Cardiol. 2024;40:662-663.
    

    >> Share

    
    
18. MORI H, Sekimoto T, Arai T, Sakai R, et al
    Mechanisms of Very Late Stent Thrombosis in Japanese Patients as Assessed by Optical Coherence Tomography.
    Can J Cardiol. 2024;40:696-704.
    

    >> Share

    
    
19. REA ABBAC, Mihajlovic V, Vishram-Nielsen JKK, Brahmbhatt DH, et al
    Pulmonary Artery Catheter Usage and Impact on Mortality in Patients With Cardiogenic Shock: Results From a Canadian Single-Centre Registry.
    Can J Cardiol. 2024;40:664-673.
    

    >> Share

    
    
20. COURTNEY BK
    Very Late Stent Thrombosis in Japan: A Look Into the Future?
    Can J Cardiol. 2024;40:705-706.
    

    >> Share

    
    

    
    Catheter Cardiovasc Interv

21. LEI J, Pu H, Zhang L, Zeng C, et al
    Drug-coated balloon therapy for in-stent restenosis in patients with iliofemoral deep vein thrombosis: A single-arm observational study.
    Catheter Cardiovasc Interv. 2024;103:752-757.
    

    >> Share

    
    
22. PENG S, Rempakos A, Mastrodemos OC, Rangan BV, et al
    Use of the Indigo CAT RX aspiration system during percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Feb 28. doi: 10.1002/ccd.30994.
    

    >> Share

    
    
23. SAGRIS M, Ktenopoulos N, Dimitriadis K, Papanikolaou A, et al
    Efficacy of intravascular lithotripsy (IVL) in coronary stenosis with severe calcification: A multicenter systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2024;103:710-721.
    

    >> Share

    
    
24. SUZUKI N
    Exploring the best strategy for true bifurcation coronary diseases to avoid a "fall between two stools".
    Catheter Cardiovasc Interv. 2024;103:817-818.
    

    >> Share

    
    
25. BASAVARAJAIAH S
    Drug coated balloons in large de novo vessels; fantasy or a reality?
    Catheter Cardiovasc Interv. 2024;103:819-820.
    

    >> Share

    
    
26. GIORDANO A, Biondi-Zoccai G
    Which is the best approach for percutaneous coronary intervention of chronic total occlusions? The one you feel most confident with!
    Catheter Cardiovasc Interv. 2024 Mar 20. doi: 10.1002/ccd.31011.
    

    >> Share

    
    
27. MERDLER I, Wallace R, Banerjee A, Medranda GA, et al
    Coronary microvascular dysfunction assessment: A comparative analysis of procedural aspects.
    Catheter Cardiovasc Interv. 2024;103:703-709.
    

    >> Share

    
    

    
    Circ Cardiovasc Imaging

28. KWON DH, Huang S, Turkmani M, Salam D, et al
    Cardiac MRI-Enriched Phenomapping Classification and Differential Treatment Outcomes in Patients With Ischemic Cardiomyopathy.
    Circ Cardiovasc Imaging. 2024;17:e016006.
    

    >> Share

    
    
29. POON EKW, Ninomiya K, Kageyama S, Guo X, et al
    Two Facets of Shear Stress Post Drug Coating Balloon: Angiography Versus Optical Coherence Tomography Fusion Approach.
    Circ Cardiovasc Imaging. 2024 Mar 22:e016279.
    

    >> Share

    
    
30. DAI X, Yu L, Yu Y, Yang W, et al
    Feasibility and Diagnostic Performance of Functional SYNTAX Score Derived From Dynamic CT Myocardial Perfusion Imaging.
    Circ Cardiovasc Imaging. 2024;17:e016155.
    

    >> Share

    
    
31. WU KC
    Phenomapping to Guide Treatment of Ischemic Cardiomyopathy With Secondary Mitral Regurgitation: One Size Does Not Fit All.
    Circ Cardiovasc Imaging. 2024;17:e016573.
    

    >> Share

    
    

    
    Circ Cardiovasc Interv

32. KERN MJ, Seto AH
    Virtual FFR From Optical Coherence Tomography: A 1-Stop Shop for PCI Guidance?
    Circ Cardiovasc Interv. 2024;17:e014077.
    

    >> Share

    
    
33. SPIRITO A, Krishnan SL, Capodanno D, Angiolillo DJ, et al
    Antiplatelet De-Escalation Strategies in Patients Undergoing Percutaneous Coronary Intervention.
    Circ Cardiovasc Interv. 2024;17:e013263.
    

    >> Share

    
    
34. DE MARIA GL, Greenwood JP, Zaman AG, Carrie D, et al
    Pressure-Controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction: The PiCSO-AMI-I Trial.
    Circ Cardiovasc Interv. 2024;17:e013675.
    

    >> Share

    
    
35. TRAVERSE JH
    Use of Pressure-Controlled Intermittent Coronary Sinus Occlusion in STEMI: The Road Not Taken!
    Circ Cardiovasc Interv. 2024;17:e014078.
    

    >> Share

    
    
36. NOBRE MENEZES M, Mamas MA
    PCI in Cancer Patients: Adding Another Piece to a Complex and Still Very Incomplete Puzzle.
    Circ Cardiovasc Interv. 2024;17:e014076.
    

    >> Share

    
    
37. CAMPOS CM, Mehran R, Capodanno D, Owen R, et al
    Risk Burden of Cancer in Patients Treated With Abbreviated Dual Antiplatelet Therapy After PCI: Analysis of Multicenter Controlled High-Bleeding Risk Trials.
    Circ Cardiovasc Interv. 2024;17:e013000.
    

    >> Share

    
    
38. JEREMIAS A, Maehara A, Matsumura M, Shlofmitz RA, et al
    Optical Coherence Tomography-Based Functional Stenosis Assessment: FUSION-A Prospective Multicenter Trial.
    Circ Cardiovasc Interv. 2024;17:e013702.
    

    >> Share

    
    
39. PRACON R, Spertus JA, Broderick S, Bangalore S, et al
    Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial.
    Circ Cardiovasc Interv. 2024 Apr 17:e013435.
    

    >> Share

    
    
40. WHITESIDE HL, Sutton NR
    Compunction: The Present Tense of Physiology to Guide Coronary Revascularization in Severe Aortic Stenosis.
    Circ Cardiovasc Interv. 2024 Apr 17:e014128.
    

    >> Share

    
    

    
    Circ Cardiovasc Qual Outcomes

41. NING H, Perak AM, Siddique J, Wilkins JT, et al
    Association Between Life's Essential 8 Cardiovascular Health Metrics With Cardiovascular Events in the Cardiovascular Disease Lifetime Risk Pooling Project.
    Circ Cardiovasc Qual Outcomes. 2024 Apr 19:e010568.
    

    >> Share

    
    
42. WADHERA RK, Joynt Maddox KE
    Policy Strategies to Advance Cardiovascular Health in the United States-Building on a Century of Progress.
    Circ Cardiovasc Qual Outcomes. 2024;17:e010149.
    

    >> Share

    
    

    
    Circ Heart Fail

43. BRYSON TD, Bhat SY, Moore C, Taube D, et al
    Targeted Gene Deletion or Antagonism of the Prostaglandin E2 EP3 Receptor Protects Against Cardiac Injury Postmyocardial Infarction.
    Circ Heart Fail. 2024;17:e011089.
    

    >> Share

    
    

    
    Circ J

44. HIRUMA T, Nakayama A, Sakamoto J, Hori K, et al
    Comprehensive Cardiac Rehabilitation Following Acute Myocardial Infarction Improves Clinical Outcomes Regardless of Exercise Capacity.
    Circ J. 2024 Apr 17. doi: 10.1253/circj.CJ-23-0668.
    

    >> Share

    
    

    
    Circulation

45. 
    Correction to: 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
    Circulation. 2024;149:e1128.
    

    >> Share

    
    

    
    Dtsch Med Wochenschr

46. FRANTZ S
    [Acute coronary syndrome].
    Dtsch Med Wochenschr. 2024;149:477.
    

    >> Share

    
    
47. THIESSEN N, Schnabel R
    [Diagnosis of acute coronary syndrome].
    Dtsch Med Wochenschr. 2024;149:488-495.
    

    >> Share

    
    
48. SCHAFER A
    [Antithrombotic therapy in acute coronary syndrome].
    Dtsch Med Wochenschr. 2024;149:496-501.
    

    >> Share

    
    
49. HUNDERTMARK M, Hofmann U
    [Treatment of Acute Coronary Syndromes].
    Dtsch Med Wochenschr. 2024;149:502-507.
    

    >> Share

    
    
50. SCHLITT A
    [Cardiac rehabilitation after acute coronary syndrome].
    Dtsch Med Wochenschr. 2024;149:508-511.
    

    >> Share

    
    

    
    Eur Heart J

51. GALIUTO L, Volpe M
    Weekly journal scan: excess incidence of unexpected health outcomes following myocardial infarction-broader paths for secondary prevention.
    Eur Heart J. 2024 Apr 15:ehae229. doi: 10.1093.
    

    >> Share

    
    

    
    Heart

52. PETERS M, Kalra D
    Young man with chest pain and an abnormal echocardiogram.
    Heart. 2024;110:656-684.
    

    >> Share

    
    
53. TUCKER B, Goonetilleke N, Patel S, Keech A, et al
    Colchicine in atherosclerotic cardiovascular disease.
    Heart. 2024 Feb 8:heartjnl-2023-323177. doi: 10.1136/heartjnl-2023-323177.
    

    >> Share

    
    

    
    Hypertension

54. MANCIA G, Brunstrom M, Burnier M, Grassi G, et al
    Rationale of the Inclusion of beta-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines.
    Hypertension. 2024 Mar 13. doi: 10.1161/HYPERTENSIONAHA.124.22821.
    

    >> Share

    
    
55. YU J, Arnott C, Li Q, Di Tanna GL, et al
    Secondary Analysis of the Salt Substitute and Stroke Study (SSaSS): Effects of Potassium-Enriched Salt on Cardiac Outcomes.
    Hypertension. 2024 Mar 11. doi: 10.1161/HYPERTENSIONAHA.123.22410.
    

    >> Share

    
    
56. TU W, Agarwal R
    Cardiovascular Benefits of Potassium-Enriched Salt Substitution: Promises and Challenges of Secondary Analyses.
    Hypertension. 2024;81:1041-1043.
    

    >> Share

    
    

    
    Int J Cardiol

57. WOLF S, Schievano E, Amidei CB, Kucher N, et al
    Mortality trend of ischemic heart disease (2008-2022): A retrospective analysis of epidemiological data.
    Int J Cardiol. 2024 Apr 12:132042. doi: 10.1016/j.ijcard.2024.132042.
    

    >> Share

    
    
58. YANG J, Zhao Y, Wang J, Ma L, et al
    Current status of emergency medical service use in ST-segment elevation myocardial infarction in China: Findings from China Acute Myocardial Infarction (CAMI) Registry.
    Int J Cardiol. 2024 Apr 11:132040. doi: 10.1016/j.ijcard.2024.132040.
    

    >> Share

    
    

    
    J Am Coll Cardiol

59. PARSA S, Saleh A, Raygor V, Hoeting N, et al
    Measurement and Application of Incidentally Detected Coronary Calcium: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:1557-1567.
    

    >> Share

    
    
60. ZERN EK, Gupta T, Ryoo Ali HJ, Thakker P, et al
    A Leadership Program to Support Career Development of Cardiovascular Chief Fellows.
    J Am Coll Cardiol. 2024;83:1623-1625.
    

    >> Share

    
    
61. ELKIND MSV
    How Physical Activity Lowers Cardiovascular Risk: Exercise Can Change Your Mind.
    J Am Coll Cardiol. 2024;83:1554-1556.
    

    >> Share

    
    
62. ZUREIGAT H, Osborne MT, Abohashem S, Mezue K, et al
    Effect of Stress-Related Neural Pathways on the Cardiovascular Benefit of Physical Activity.
    J Am Coll Cardiol. 2024;83:1543-1553.
    

    >> Share

    
    
63. WONG ND, Fan W, Hu X, Ballantyne C, et al
    Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled Prospective Cohort.
    J Am Coll Cardiol. 2024;83:1511-1525.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

64. ZHANG G, Jiang W, He F, Fu J, et al
    LDL-C and TC mediate the risk of PNPLA3 inhibition on cardiovascular diseases.
    J Clin Endocrinol Metab. 2024 Apr 18:dgae264. doi: 10.1210.
    

    >> Share

    
    
65. CHE J, He N, Kuang X, Zheng C, et al
    Dietary n-3 fatty acids intake and all-cause and cardiovascular mortality in patients with pre-diabetes and diabetes.
    J Clin Endocrinol Metab. 2024 Apr 16:dgae265. doi: 10.1210.
    

    >> Share

    
    

    
    J Mol Cell Cardiol

66. CREA F, Iannaccone G, La Vecchia G, Montone RA, et al
    An update on the mechanisms of Takotsubo syndrome: "At the end an acute coronary syndrome".
    J Mol Cell Cardiol. 2024 Apr 17:S0022-2828(24)00053.
    

    >> Share

    
    

    
    Mol Cell Biochem

67. DUAN X, Liu R, Xi Y, Tian Z, et al
    The mechanisms of exercise improving cardiovascular function by stimulating Piezo1 and TRP ion channels: a systemic review.
    Mol Cell Biochem. 2024 Apr 16. doi: 10.1007/s11010-024-05000.
    

    >> Share

    
    

    
    N Engl J Med

68. STEG PG
    Routine Beta-Blockers in Secondary Prevention - On Injured Reserve.
    N Engl J Med. 2024;390:1434-1436.
    

    >> Share

    
    
69. RAO SV
    Mechanical Circulatory Support in Cardiogenic Shock - Persistence and Progress.
    N Engl J Med. 2024;390:1436-1438.
    

    >> Share

    
    
70. MOLLER JE, Engstrom T, Jensen LO, Eiskjaer H, et al
    Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock.
    N Engl J Med. 2024;390:1382-1393.
    

    >> Share

    
    

    
    PLoS One

71. RYE CS, Ofstad AP, Asvold BO, Romundstad PR, et al
    The influence of diagnostic subgroups, patient- and hospital characteristics for the validity of cardiovascular diagnoses-Data from a Norwegian hospital trust.
    PLoS One. 2024;19:e0302181.
    

    >> Share

    
    
72. CHANG PC, Lee HL, Wo HT, Liu HT, et al
    Vericiguat suppresses ventricular tachyarrhythmias inducibility in a rabbit myocardial infarction model.
    PLoS One. 2024;19:e0301970.
    

    >> Share

    
    
73. WU W, Banga A, Oguz UM, Zhao S, et al
    Experimental validation and clinical feasibility of 3D reconstruction of coronary artery bifurcation stents using intravascular ultrasound.
    PLoS One. 2024;19:e0300098.
    

    >> Share

    
    
74. KIM MS, Kim SH
    Health information-seeking behavior in patients with coronary artery disease: Activating methods.
    PLoS One. 2024;19:e0300755.
    

    >> Share

    
    
75. GHALI H, El Hraiech A, Ben Souda H, Karray M, et al
    Therapeutic education of patients with coronary heart disease: Impact of digital platform monitoring in preventing major cardiovascular events in Tunisia: Study protocol.
    PLoS One. 2024;19:e0300250.
    

    >> Share

    
    
76. TRAN DC, Le LHG, Thai TT, Van Hoang S, et al
    Effect of AGTR1 A1166C genetic polymorphism on coronary artery lesions and mortality in patients with acute myocardial infarction.
    PLoS One. 2024;19:e0300273.
    

    >> Share

    
    

    
    Thromb Haemost

77. LIANG B, Zha L, Peng B, Chen Q, et al
    Association of Cardiovascular Health with the Incidence of Venous Thromboembolism: A Prospective Study of 275,149 Participants from the UK Biobank.
    Thromb Haemost. 2024 Apr 12. doi: 10.1055/a-2305-6631.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share